Parametric Portfolio Associates’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
BBA
CS
TCM
Parametric Portfolio Associates's BLUE Position: Q1 2022 in Review
Parametric Portfolio Associates increased its bluebird bio (BLUE) stake by 111% in Q1 2022, buying an estimated $836K and bringing the position to 12,031 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2709.
Parametric Portfolio Associates first reported a position in BLUE in Q1 2015 and has held it in 29 quarters since. The position peaked at $7.87M in Q4 2020. 174 funds tracked by Wall St. Rank hold BLUE as of Q1 2022.
- Parametric Portfolio Associates held 12,031 shares of bluebird bio worth $1.17M as of Q1 2022.
- Parametric Portfolio Associates bought 6,335 bluebird bio shares in Q1 2022, an estimated $836K.
- bluebird bio made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2709 holding.
- Parametric Portfolio Associates first reported a position in bluebird bio in Q1 2015 and has held it in 29 quarters since.
- Parametric Portfolio Associates's bluebird bio position peaked at $7.87M in Q4 2020.
- 174 funds tracked by Wall St. Rank held bluebird bio as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.